Skip to main content

Month: August 2022

Report On Financial Results For The Three And Six Months Ended June 30, 2022

TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Mitchell Cohen, Chief Executive Officer and President of Urbanfund Corp. (TSX-V: UFC) (“Urbanfund” or the “Company”), confirmed today that the Company has filed its financial statements for the three and six months ended June 30, 2022 (the “Consolidated Financial Statements”) and corresponding Management’s Discussion and Analysis (“MD&A”). BUSINESS OVERVIEW AND STRATEGY Business Overview Urbanfund Corp. is an incorporated entity listed on the TSX Venture Exchange (“TSX-V”) under the symbol UFC. The Company is a reporting issuer in Alberta, British Columbia and Ontario. Urbanfund’s focus is to invest in Canadian real estate and real estate related projects with a focus on a mix of both residential and commercial properties. The Company’s assets are located in Toronto, Brampton, Belleville,...

Continue reading

CVW CleanTech Announces Q2 2022 Results

CALGARY, Alberta, Aug. 25, 2022 (GLOBE NEWSWIRE) — CVW CleanTech Inc. (the “Company” or “CVW CleanTech”) (TSX-V: CVW)  is pleased to announce its operating and financial results the three and six month periods ended June 30, 2022. For complete details, please refer to the condensed interim financial statements and the associated Management Discussion and Analysis for the period ended  June 30, 2022, available on SEDAR: (www.sedar.com) or on the Company’s website: www.CVWCleanTech.com/ Management and the Board of Directors continue to seek to commercialize CVW CleanTech’s technologies, to a broader range of partners than previously contemplated. Further, we are considering application of its technologies and financial structuring to a broader clean tech industry. Financial highlightsThe cash balance...

Continue reading

Koss Corporation Releases Fourth Quarter Results

MILWAUKEE, Aug. 25, 2022 (GLOBE NEWSWIRE) — Koss Corporation (NASDAQ: KOSS) (the “Company”), the U.S. based high-fidelity headphone company, has reported its results for the fourth quarter ended June 30, 2022. Sales for the fourth fiscal quarter were $4,191,761, a decline of 22.7% compared to $5,420,471 for the same period in the prior year. The net income for the three months ended June 30, 2022 was $385,595, which is an increase over the net income of $331,943 for the same three month period one year ago. Both basic and diluted income per common share for the quarter were $0.04 compared to a basic income per common share of $.04 and a diluted income per common share of $0.03 for the three-month period one year ago. “We saw a decline in sales for the quarter,” Michael J. Koss, Chairman and CEO, said today. “We appear to be experiencing...

Continue reading

BlackRock® Canada Announces Final August Cash Distributions for the iShares® Premium Money Market ETF

TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the final August 2022 cash distributions for the iShares Premium Money Market ETF. Unitholders of record on August 26, 2022 will receive cash distributions payable on August 31, 2022. Details regarding the final “per unit” distribution amounts are as follows:Fund Name Fund Ticker Cash Distribution Per Unit ($)iShares Premium Money Market ETF CMR 0.088Further information on the iShares ETFs can be found at http://www.blackrock.com/ca. About BlackRock BlackRock’s purpose is to help more and more people experience financial well-being. As a fiduciary to investors and a leading provider of financial technology, we help millions of people...

Continue reading

Molecular Partners Reports Corporate Highlights and H1 2022 Financials

Continued development of MP0317, with initial clinical data from Phase 1 study expected in the second half of 2022 Initiation of Phase 1 study for MP0533 expected by year end Continued progression of proprietary DARPin-conjugated radioligand therapeutics; innate immune cell engagers; next-generation T-cell engagers; and antiviral DARPins MP0310 Phase 1 enrollment complete; no additional studies currently planned In January 2022, Molecular Partners received a payment of CHF 150 million from Novartis to license ensovibep Novartis is responsible for further development, manufacturing, and commercialization activities. An application for Emergency Use Authorization (EUA) was submitted to the U.S. Food and Drug Administration (FDA) by Novartis for ensovibep Cash position of CHF 285.1 million as of June 30, 2022, anticipated to support operations...

Continue reading

Emily Melton to Step Down from Shift’s Board of Directors

SAN FRANCISCO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Shift Technologies, Inc. (Nasdaq: SFT) announced today that Emily Melton, Lead Director who has served on the company’s Board since 2014, will be stepping down from the Board, effective August 31. Jason Krikorian, company Director since 2018, will succeed Melton as Lead Director. “Every entrepreneur should be so lucky as to have an early investor like Emily – she has been an invaluable partner and I could not imagine this journey without her,” said George Arison, Shift’s co-founder and Board Chair. “Since co-leading our Series A, she has been a wonderful supporter, advisor, and mentor to all the leaders at Shift. Thanks to Emily’s sound business judgment, generosity of time, and deep experience in company building, I’ve become a much better founder and leader. I will miss her...

Continue reading

Capital City Bank Group, Inc. Appoints Jep Larkin Chief Financial Officer as J. Kimbrough Davis Announces Retirement

TALLAHASSEE, Fla., Aug. 25, 2022 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) today announced that, effective January 1, 2023, Jep Larkin will be named Executive Vice President and Chief Financial Officer to succeed J. Kimbrough Davis, who has elected to retire after a distinguished 41 years with the company.  Mr. Davis will continue his existing duties until December 31, 2022, while ensuring a smooth transition of responsibilities to Mr. Larkin. Mr. Larkin, 58, joined Capital City in 1986 and has worked closely with our CFO throughout his career.  He is currently the Senior Vice President and Controller of CCBG and a member of the Senior Management Committee.  After serving in various credit roles early in his career and leading CCBG’s Internal Audit Division from 1992 to 2002, he was appointed Controller of...

Continue reading

Inari Medical to Present at Upcoming Investor Conferences

IRVINE, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present at the following investor conferences:2022 Wells Fargo Healthcare ConferenceFireside chat on Friday, September 9, 2022, at 8:35 a.m. Eastern Time in Boston, MA.Morgan Stanley 20th Annual Global Healthcare ConferenceFireside chat on Monday, September 12, 2022, at 8:10 a.m. Eastern Time in New York, NY.A live audio webcast and replay of the Wells Fargo and Morgan Stanley conference may be accessed on the “Investor Relations” section of the company’s website at: https://www.inarimedical.com/ About Inari Medical, Inc.Inari Medical, Inc. is a medical device...

Continue reading

Freddie Mac Issues Monthly Volume Summary for July 2022

MCLEAN, Va., Aug. 25, 2022 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today posted to its website its Monthly Volume Summary for July 2022, which provides information on Freddie Mac’s mortgage-related portfolios, securities issuance, risk management, delinquencies, debt activities, and other investments. Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders, and taxpayers. Learn more at FreddieMac.com, Twitter @FreddieMac, and Freddie Mac’s blog FreddieMac.com/blog. MEDIA CONTACT: Fred Solomon703-903-3861Frederick_Solomon@freddiemac.com INVESTOR...

Continue reading

Urbanimmersive Announces Its 2022 Third Quarter Financial Results

SAINT-HUBERT, Quebec, Aug. 25, 2022 (GLOBE NEWSWIRE) — Urbanimmersive Inc. (“Urbanimmersive,” the “Company” or “UI”) (TSV-V UI) (OTCQB: UBMRF) today announced select financial results and presents business highlights for its third quarter ended June 30, 2022. The financial statements and related management’s discussion and analysis (“MD&A”) can be viewed on SEDAR at https://www.sedar.com/. HIGHLIGHTSFor its third quarter ended on June 30, 2022 (Q3-22), the Company’s revenues totaled $2,850k compared to $1,102k for Q3-21, an increase of +$1,748k or 159%; For Q3-22, the Company sold 6,270 immersive 3D tours compared to 1,551 tours in Q3-21, an increase of 4,719 tours (304%); For Q3-22, EBITDA totalled $296k compared to $103k for Q3-21, an increase of $193k; For Q3-22, operating activities generated cash flows of +$365k...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.